Dubai, United Arab Emirates - April 14, 2021:  In line with the aim of the Dubai Health Authority (DHA) to provide high quality internationally recognised standards of accessible patient-centered care, DHA has signed a MoU with Al Jalila Children's Specialty Hospital. 

 

The MoU will help facilitate collaboration in the field of medical education and research. It will also help in exchange of expertise and will foster collaboration in specialised paediatric fields of medicine such as organ transplant.

 

The MoU was signed by His Excellency Awadh Al Ketbi, Director General of the Dubai Health Authority and Dr. Abdulla Ibrahim Al Khayat, Chief Executive Officer of Al Jalila Children's Specialty Hospital at the DHA Headquarters. 

 

The MoU was signed in the presence of Dr. Alawi Alsheikh Ali, Deputy Director General of the DHA, Jamal Abdul Salam, CEO of Dubai Healthcare City Authority, Dr. Ramadan Alblooshi, Chief Regulatory Officer at Dubai Healthcare City Authority, Dr. Mohamed Al Awadhi, Chief Operating Officer at Al Jalila Children's Specialty Hospital and a number of senior DHA officials. 

 

Al Ketbi highlighted that DHA is keen to collaborate with esteemed medical and educational institutions with an aim to provide high-quality patient centered care. 

 

He added that fostering medical education and research, collaborating and sharing expertise particularly in rare medical fields and knowledge transfer are key areas to help further develop and bolster Dubai’s health sector. 

 

His Excellency pointed out that DHA’s Latifa Hospital for Women and Children and Al Jalila Children’s Specialty Hospital are recognized not only in the country but also regionally for their expertise and this MoU will further open up avenues for collaboration with an aim to provide the highest quality of specialized pediatric care.